🔗 Permalink

Assignee profile:

Acceleron Pharma, Inc.

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

207

Last publication date:

2025-06-19

Patent Grants:

166

Last grant date:

2026-03-24

Quarterly Acceleron Pharma, Inc. Patent Applications

Top Inventors for applications by Acceleron Pharma, Inc.

These are the the leading inventors for applications assigned to Acceleron Pharma, Inc.:

Ravindra Kumar 116 Acton, MA United States
Jasbir Seehra 106 Lexington, MA United States
John Knopf 85 Carlisle, MA United States
ASYA GRINBERG 49 LEXINGTON, MA United States

Roselyne Castonguay 21 Watertown, MA United States
Matthew L. Sherman 18 Newton, MA United States
Dianne Sako 16 Medford, MA United States
Robert Scott Pearsall 13 North Reading, MA United States

Dianne S. Sako 13 Medford, MA United States
Ravindra KUMAR 13 Cambridge, MA United States
Robert Scott Pearsall 13 Woburn, MA United States
Kenneth M. Attie 10 Boston, MA United States

John KNOPF 8 Cambridge, MA United States
KRISTIAN PIETRAS 7 STOCKHOLM, Sweden
Niels Borgstein 7 Medfield, MA United States
Roselyne Castonguay 7 Malden, MA United States

Robert S. Pearsall 7 North Reading, MA United States
Jonathan Belk 7 Lebanon, NH United States
Naga Venkata Sai Rajasekhar Suragani 7 Norwood, MA United States
Rita Steeves 6 Stoneham, MA United States

Asya Grinberg 6 Cambridge, MA United States
Jennifer Lachey 6 Arlington, MA United States
Roselyne Castonguay 5 Cambridge, MA United States
Rajasekhar Naga Venkata Sai Suragani 5 Wrentham, MA United States

Naga Venkata Sai Rajasekhar Suragani 5 Wrentham, MA United States
ROBERT S. PEARSALL 5 WOBURN, MA United States
Asya Grinberg 5 Boston, MA United States
Yossi DAGON 5 Cambridge, MA United States

Acceleron Pharma, Inc. 5 Cambridge, MA United States
Robert Scott Pearsall 4 Cambridge, MA United States
Dianne Sako 4 Cambridge, MA United States
Gang LI 4 Cambridge, MA United States

Eric Werner 4 Milton, MA United States
Nathan J. SHARKEY 4 Lebanon, NH United States
Diana Martik 3 Cambridge, MA United States
Gang LI 3 Sudbury, MA United States

Monique Davies 3 Harpswell, ME United States
David Buckler 3 Chester, NJ United States
Ravindra Kumar 3 Shrewsbury, MA United States
Janja Cosic 3 Arlington, MA United States

Rachel Kent 3 Boxborough, MA United States
Dianne S. Sako 2 Cambridge, MA United States
Marat B. Alimzhanov 2 Wellesley, MA United States
Hiroyuki SATO 2 Osaka, Japan

Christopher Robert Rovaldi 2 Swampscott, MA United States
Shuchi Sumant Pandya 2 Newton, MA United States
Ravindra Kumar 2 Concord, MA United States
Yuuko Isono 2 Chiba, Japan

Yossi Dagon 2 Framingham, MA United States
Paul B. Yu 2 Boston, MA United States
Tsutomu Yoshikawa 2 Chiba, Japan
Kenji Nagahari 2 Tokyo, Japan

Alan Koncarevic 2 Boston, MA United States
Rajasekhar Naga Venkata Sai Suragani 2 Norwood, MA United States
Motoyuki Otsuka 2 Tokyo, Japan
Ryotaro Irie 2 Chiba, Japan

Kaoru Otsuka 2 Saitama, Japan
Shizuko Ishii 2 Chiba, Japan
Ai Wakamatsu 2 Chiba, Japan
Tomoyasu Sugiyama 2 Tokyo, Japan

Tetsuji Otsuki 2 Chiba, Japan
Ichiro Tamechika 2 Osaka, Japan
Takao Isogai 2 Ibaraki, Japan
Yasuhiko Masuho 2 Tokyo, Japan

Jun-ichi Yamamoto 2 Chiba, Japan
Naohiko Seki 2 Chiba, Japan
Yuri Hio 2 Chiba, Japan
Patrick ANDRE 2 Short Hills, NJ United States

Keiichi NAGAI 2 Tokyo, Japan
Abderrahmane Laadem 2 Belle Mead, NJ United States
Roselyne Castonguay 1 Watertwon, MA United States
Dianne S. Sako 1 Federal Way, WA United States

Jabir Seehra 1 Lexington, MA United States
Erik M. Vogan 1 Cambridge, MA United States
Joseph Grattin Reynolds 1 Cambridge, MA United States
Paul YU 1 Boston, MA United States

Robert S. Pearsall 1 North Reading Acton, MA United States
Pedro Martinez 1 Cambridge, MA United States
Janethe de Oliveira Pena 1 Cambridge, MA United States
Alan Koncarevic 1 Chicago, IL United States

Jay Backstrom 1 Leawood, KS United States
Christopher Rovaldi 1 Swampscott, MA United States
Patrick Andre 1 Cambridge, MA United States
Jonathan Toshi Lu 1 Cambridge, MA United States

Erik Martinez-Hackert 1 Okemos, MI United States
Erik M. Vogan 1 Medford, MA United States
Dianne Sako 1 Federal Way, WA United States
Rajesh Chopra 1 Sutton, United Kingdom

Acceleron Pharma, Inc. 1 , United States
Rajasekhar Naga Venkata Sai Suragani 1 Cambridge, MA United States
Tzu-Hsing Kuo 1 Chestnut Hill, MA United States
Erik Vogan 1 Medford, MA United States

Sachindra Joshi 1 Cambridge, MA United States

Recent patent applications by Acceleron Pharma, Inc.

Acceleron Pharma, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-06-19

US20250197469A1

Chemistry; metallurgy

ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF

#2 | 2025-04-03

US20250109184A1

Chemistry; metallurgy

TGF-BETA RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF

#3 | 2025-03-06 ✅ Patent 12,583,906 granted on 2026-03-24

US20250074968A1

Chemistry; metallurgy

ACTRII PROTEINS AND USE IN TREATING POST-CAPILLARY PULMONARY HYPERTENSION

#4 | 2025-02-06

US20250042963A1

Chemistry; metallurgy

METHODS FOR TREATING MYELOPROLIFERATIVE DISORDERS

#5 | 2024-11-07

US20240366720A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#6 | 2024-07-11 ✅ Patent 12,527,839 granted on 2026-01-20

US20240226235A1

Human necessities

TREATMENTS FOR SYSTEMIC SCLEROSIS

#7 | 2023-12-14

US20230398182A1

Human necessities

TREATMENTS FOR HERMANSKY-PUDLAK SYNDROME

#8 | 2023-12-14

US20230398181A1

Human necessities

TREATMENTS FOR COMPLICATIONS ASSOCIATED WITH CHRONIC LIVER DISEASE

#9 | 2023-07-27 ✅ Patent 12,145,970 granted on 2024-11-19

US20230234998A1

Chemistry; metallurgy

Twisted gastrulation polypeptides and uses thereof

#10 | 2023-07-27 ✅ Patent 12,343,378 granted on 2025-07-01

US20230233648A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#11 | 2022-11-24 ✅ Patent 12,103,959 granted on 2024-10-01

US20220372107A1

Chemistry; metallurgy

Multispecific binders of TGFBeta-superfamily ligands and uses thereof

#12 | 2022-09-29 ✅ Patent 12,240,887 granted on 2025-03-04

US20220306724A1

Chemistry; metallurgy

Variant ActRIIB proteins and uses thereof

#13 | 2022-09-22 ✅ Patent 12,144,860 granted on 2024-11-19

US20220296708A1

Human necessities

ALK1 receptor and ligand antagonists and uses thereof

#14 | 2022-09-15 ✅ Patent 12,024,563 granted on 2024-07-02

US20220289852A1

Chemistry; metallurgy

ALK7 antagonists and uses thereof

#15 | 2022-08-18 ✅ Patent 11,976,111 granted on 2024-05-07

US20220259297A1

Chemistry; metallurgy

ActRIIa and ALK4 polypeptides for treating kidney fibrosis, inflammation and injury

#16 | 2022-08-04 ✅ Patent 12,258,380 granted on 2025-03-25

US20220242927A1

Chemistry; metallurgy

ALK4:actriib heteromultimers and uses thereof

#17 | 2022-04-21 ✅ Patent 11,827,689 granted on 2023-11-28

US20220119491A1

Chemistry; metallurgy

ALK7:ActRIIB heteromultimers and uses thereof

#18 | 2022-01-20

US20220017600A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION

#19 | 2021-12-16

US20210388104A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION

#20 | 2021-11-25 ✅ Patent 12,054,753 granted on 2024-08-06

US20210363502A1

Chemistry; metallurgy

Methods of treatment of muscular dystrophy with ALK4:ActRIIB heteromultimers

#21 | 2021-10-21 ✅ Patent 11,708,414 granted on 2023-07-25

US20210324089A1

Chemistry; metallurgy

ALK7 binding proteins and uses thereof

#22 | 2021-10-21 ✅ Patent 12,195,519 granted on 2025-01-14

US20210324040A1

Chemistry; metallurgy

Transforming growth factor-beta (TGF-beta) receptor type II fusion polypeptides

#23 | 2021-10-21 ✅ Patent 12,194,076 granted on 2025-01-14

US20210322514A1

Human necessities

Methods and compositions for treating myelofibrosis

#24 | 2021-10-07 ✅ Patent 12,042,524 granted on 2024-07-23

US20210308206A1

Human necessities

Activin type 2 receptor binding proteins methods of making them

#25 | 2021-09-30

US20210300991A1

Chemistry; metallurgy

ENDOGLIN POLYPEPTIDES AND USES THEREOF

#26 | 2021-09-30 ✅ Patent 11,318,188 granted on 2022-05-03

US20210299220A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#27 | 2021-09-30 ✅ Patent 11,497,794 granted on 2022-11-15

US20210299216A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#28 | 2021-09-09 ✅ Patent 11,807,673 granted on 2023-11-07

US20210277082A1

Chemistry; metallurgy

Methods and compositions for increasing red blood cells

#29 | 2021-06-17 ✅ Patent 11,497,792 granted on 2022-11-15

US20210177741A1

Human necessities

Methods for treatment of Duchenne muscular dystrophy with follistatin polypeptides

#30 | 2021-06-03 ✅ Patent 11,279,746 granted on 2022-03-22

US20210163569A1

Chemistry; metallurgy

ALK4:ActRIIB heteromultimers and uses thereof

#31 | 2021-05-20 ✅ Patent 11,440,949 granted on 2022-09-13

US20210147508A1

Chemistry; metallurgy

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

#32 | 2021-01-28 ✅ Patent 11,622,992 granted on 2023-04-11

US20210023174A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#33 | 2021-01-07

US20210002342A1

Chemistry; metallurgy

BMPRII POLYPEPTIDES AND USES THEREOF

#34 | 2020-12-31 ✅ Patent 11,219,666 granted on 2022-01-11

US20200405814A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#35 | 2020-12-24 ✅ Patent 11,065,303 granted on 2021-07-20

US20200397865A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#36 | 2020-12-24 ✅ Patent 11,642,394 granted on 2023-05-09

US20200397863A1

Human necessities

Methods and compositions using GDF15 polypeptides for increasing red blood cells

#37 | 2020-12-17 ✅ Patent 11,981,738 granted on 2024-05-14

US20200392233A1

Chemistry; metallurgy

ALK7 binding proteins and uses thereof

#38 | 2020-12-17 ✅ Patent 10,946,067 granted on 2021-03-16

US20200390860A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#39 | 2020-12-10 ✅ Patent 10,973,880 granted on 2021-04-13

US20200384080A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#40 | 2020-10-15 ✅ Patent 11,951,156 granted on 2024-04-09

US20200323955A1

Human necessities

Methods for treating pulmonary hypertension with a ligand binding domain of a TGF-beta type II receptor

#41 | 2020-07-02 ✅ Patent 11,168,311 granted on 2021-11-09

US20200208124A1

Chemistry; metallurgy

Methods for treating anemia in a subject in need thereof

#42 | 2020-06-25 ✅ Patent 11,162,085 granted on 2021-11-02

US20200199548A1

Chemistry; metallurgy

Methods for treating anemia in a subject in need thereof

#43 | 2020-06-25 ✅ Patent 11,155,791 granted on 2021-10-26

US20200199547A1

Chemistry; metallurgy

Methods for treating anemia in a subject in need thereof

#44 | 2020-06-25 ✅ Patent 10,829,532 granted on 2020-11-10

US20200199186A1

Chemistry; metallurgy

Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels

#45 | 2020-06-11 ✅ Patent 10,829,533 granted on 2020-11-10

US20200181218A1

Chemistry; metallurgy

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

#46 | 2020-06-11 ✅ Patent 10,889,626 granted on 2021-01-12

US20200181217A1

Chemistry; metallurgy

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

#47 | 2020-05-28 ✅ Patent 11,590,201 granted on 2023-02-28

US20200164029A1

Human necessities

Endoglin peptides to treat fibrotic diseases

#48 | 2020-05-21 ✅ Patent 11,066,654 granted on 2021-07-20

US20200157512A1

Chemistry; metallurgy

Methods and compositions for reducing serum lipids

#49 | 2020-05-21 ✅ Patent 11,008,377 granted on 2021-05-18

US20200157182A1

Chemistry; metallurgy

Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptides

#50 | 2020-05-14 ✅ Patent 10,968,282 granted on 2021-04-06

US20200148788A1

Chemistry; metallurgy

Methods for screening compounds for increasing thermogenic adipocytes

#51 | 2020-04-16 ✅ Patent 10,829,534 granted on 2020-11-10

US20200115428A1

Chemistry; metallurgy

Methods and compositions for increasing red blood cells

#52 | 2020-04-09 ✅ Patent 11,260,107 granted on 2022-03-01

US20200109193A1

Chemistry; metallurgy

Methods and compositions for treating ulcers

#53 | 2020-03-19 ✅ Patent 11,059,894 granted on 2021-07-13

US20200087406A1

Chemistry; metallurgy

ALK7 binding proteins and uses thereof

#54 | 2020-03-05 ✅ Patent 11,524,990 granted on 2022-12-13

US20200071383A1

Chemistry; metallurgy

Methods for treating vascular eye disorders with ActRII antagonists

#55 | 2020-03-05

US20200071382A1

Chemistry; metallurgy

TGF-BETA SUPERFAMILY HETEROMULTIMERS AND USES THEREOF

#56 | 2020-02-20 ✅ Patent 11,208,460 granted on 2021-12-28

US20200055920A1

Chemistry; metallurgy

Single-arm type I and type II receptor fusion proteins and uses thereof

#57 | 2020-02-20 ✅ Patent 11,267,865 granted on 2022-03-08

US20200055919A1

Chemistry; metallurgy

Variant ActRIIB proteins and uses thereof

#58 | 2019-12-12 ✅ Patent 11,028,145 granted on 2021-06-08

US20190375820A1

Chemistry; metallurgy

ALK7:actriib heteromultimers and uses thereof

#59 | 2019-12-05 ✅ Patent 11,000,565 granted on 2021-05-11

US20190365844A1

Human necessities

Methods of increasing muscle mass by administration of activin type 2 receptor antibodies

#60 | 2019-09-19 ✅ Patent 10,745,462 granted on 2020-08-18

US20190284257A1

Chemistry; metallurgy

Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide

#61 | 2019-08-29 ✅ Patent 10,689,427 granted on 2020-06-23

US20190263876A1

Chemistry; metallurgy

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

#62 | 2019-08-01 ✅ Patent 10,829,531 granted on 2020-11-10

US20190233486A1

Chemistry; metallurgy

Methods for treating myelodysplastic syndromes and sideroblastic anemias

#63 | 2019-07-25 ✅ Patent 10,906,958 granted on 2021-02-02

US20190225669A1

Chemistry; metallurgy

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

#64 | 2019-06-27 ✅ Patent 11,129,873 granted on 2021-09-28

US20190192625A1

Human necessities

Method for promoting bone growth using activin-actriia antagonists

#65 | 2019-04-04 ✅ Patent 10,738,098 granted on 2020-08-11

US20190100570A1

Chemistry; metallurgy

ALK4:ActRIIB heteromultimers and uses thereof

#66 | 2019-02-14

US20190048063A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION

#67 | 2018-11-29 ✅ Patent 10,954,279 granted on 2021-03-23

US20180340013A1

Chemistry; metallurgy

Methods and compositions for treatment of disorders with follistatin polypeptides

#68 | 2018-11-15 ✅ Patent 11,021,527 granted on 2021-06-01

US20180327477A1

Chemistry; metallurgy

Transforming growth factor beta receptor type II fusion polypeptides

#69 | 2018-11-15 ✅ Patent 10,765,626 granted on 2020-09-08

US20180325808A1

Human necessities

Methods for treatment of charcot-marie-tooth disease with follistatin polypeptides

#70 | 2018-10-25

US20180305438A1

Chemistry; metallurgy

BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH

#71 | 2018-10-25 ✅ Patent 11,001,614 granted on 2021-05-11

US20180305427A1

Chemistry; metallurgy

Method for treating a muscle-related disorder with follistatin-related fusion proteins

#72 | 2018-09-13 ✅ Patent 10,981,972 granted on 2021-04-20

US20180258156A1

Chemistry; metallurgy

Endoglin polypeptides and uses thereof

#73 | 2018-08-09 ✅ Patent 11,203,624 granted on 2021-12-21

US20180222956A1

Chemistry; metallurgy

Method for treating myelofibrosis comprising administering a transforming growth factor beta type II receptor antagonist

#74 | 2018-08-09 ✅ Patent 10,695,405 granted on 2020-06-30

US20180221447A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#75 | 2018-07-26 ✅ Patent 10,603,359 granted on 2020-03-31

US20180207236A1

Human necessities

Methods and compositions using GDF15 polypeptides for increasing red blood cells

#76 | 2018-07-12 ✅ Patent 10,487,144 granted on 2019-11-26

US20180194834A1

Chemistry; metallurgy

Methods for treating ulcers in a hemoglobinopathy anemia with a soluble actRIIB polypeptide

#77 | 2018-07-05 ✅ Patent 10,344,066 granted on 2019-07-09

US20180186851A1

Chemistry; metallurgy

Methods and compositions for increasing red blood cells

#78 | 2018-06-28

US20180179293A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION

#79 | 2018-06-28 ✅ Patent 10,316,076 granted on 2019-06-11

US20180179261A1

Chemistry; metallurgy

Transforming growth factor-beta receptor type II fusion polypeptides

#80 | 2018-06-14 ✅ Patent 10,934,532 granted on 2021-03-02

US20180163187A1

Chemistry; metallurgy

ALK4.ActRIIB heteromultimers

#81 | 2018-06-14

US20180162954A1

Chemistry; metallurgy

METHODS FOR INCREASING THERMOGENIC ADIPOCYTES

#82 | 2018-05-10

US20180125928A1

Human necessities

TREATMENT OF BETA-THALASSEMIA USING ACTRII LIGAND TRAPS

#83 | 2018-03-29

US20180086806A9

Chemistry; metallurgy

BMPRII POLYPEPTIDES AND USES THEREOF

#84 | 2018-03-22 ✅ Patent 10,358,633 granted on 2019-07-23

US20180080012A1

Chemistry; metallurgy

Method for producing an ActRIIB-Fc fusion polypeptide

#85 | 2018-02-22 ✅ Patent 10,722,558 granted on 2020-07-28

US20180050089A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#86 | 2018-02-08 ✅ Patent 10,131,700 granted on 2018-11-20

US20180037622A1

Chemistry; metallurgy

Methods for treating refractory anemia with ringed sideroblasts

#87 | 2017-12-21 ✅ Patent 11,471,510 granted on 2022-10-18

US20170360887A1

Human necessities

Activin-ActRII antagonists and uses for treating anemia

#88 | 2017-11-16

US20170327800A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS

#89 | 2017-11-09 ✅ Patent 10,968,262 granted on 2021-04-06

US20170320925A1

Chemistry; metallurgy

Methods of increasing sarcolemmal utrophin

#90 | 2017-10-26 ✅ Patent 10,501,547 granted on 2019-12-10

US20170306028A1

Chemistry; metallurgy

ALK7 binding proteins and uses thereof

#91 | 2017-10-12 ✅ Patent 10,301,372 granted on 2019-05-28

US20170291935A1

Chemistry; metallurgy

Methods for treating vascular eye disorders with actrii antagonists

#92 | 2017-10-12

US20170291933A1

Chemistry; metallurgy

BMPRII POLYPEPTIDES AND USES THEREOF

#93 | 2017-10-05 ✅ Patent 10,307,455 granted on 2019-06-04

US20170281711A1

Human necessities

Activin type 2 receptor antibodies

#94 | 2017-09-28 ✅ Patent 11,123,430 granted on 2021-09-21

US20170274077A1

Human necessities

Methods for increasing red blood cell levels and treating ineffective erythropoiesis

#95 | 2017-07-20 ✅ Patent 10,377,996 granted on 2019-08-13

US20170204382A1

Chemistry; metallurgy

Methods of identifying ActRIIB variants

#96 | 2017-06-01

US20170152490A9

Chemistry; metallurgy

USE OF ACTIVIN RECEPTOR-LIKE KINASE 1 (ALK-1) ANTAGONISTS IN THE TREATMENT OF CANCER

#97 | 2017-05-25 ✅ Patent 10,239,940 granted on 2019-03-26

US20170145085A1

Chemistry; metallurgy

Method of promoting bone growth by an anti-actriia antibody

#98 | 2017-03-02 ✅ Patent 10,259,861 granted on 2019-04-16

US20170058016A1

Chemistry; metallurgy

Variants derived from ActRIIB and uses therefor

#99 | 2017-02-09 ✅ Patent 9,884,900 granted on 2018-02-06

US20170037100A1

Chemistry; metallurgy

Methods for treating Janus kinase-associated disorders by administering soluble transforming growth factor beta type II receptor

#100 | 2016-12-01 ✅ Patent 9,624,301 granted on 2017-04-18

US20160347845A1

Chemistry; metallurgy

Polynucleotides encoding an actriib antibody

Also check out Acceleron Pharma Inc.'s (Cambridge, United States) applicant profile with 140 patent applications submitted.

AssigneeID:

1528 ⎘